FDA's Overreach on Compounded Peptides The peptide problem: Hype is outrunning the evidence RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Why Are People Injecting Themselves with Peptides? The New Yorker